Posts filtered by tags: Takeda[x]


 

Investors have poured almost $1 billion into startups using data to upend the expensive and slow process of finding new drugs — but an uphill battle awaits

Developing an innovative new medicine is a long and expensive slog.  Upending that process is the goal of a wave of new startups. Investors have put just under $1 billion into the area over the last five years, according to an analysis done by PitchBook for Business Insider.  These new companies are putting data and technology at the center of their approaches, but the sorry state of the two in healthcare could undermine the whole enterprise. Visit BusinessInsider.com for more stories. Making...
Tags: New York, Microsoft, US, Trends, Startup, Fda, Novartis, Pfizer, Mitchell, US Food and Drug Administration, Los Angeles California, PitchBook, LabCorp, Cambridge Massachusetts, Takeda, ZS Associates


Creating a new drug takes a decade and costs a fortune. Investors have poured almost $1 billion into startups trying to change that.

Developing an innovative new medicine is a long and expensive slog.  Upending that process is the goal of a wave of new startups. Investors have put just under $1 billion into the area over the last five years, according to an analysis done by PitchBook for Business Insider.  These new companies are putting data and technology at the center of their approaches, but the sorry state of the two in healthcare could undermine the whole enterprise. Visit BusinessInsider.com for more stories. Making...
Tags: New York, Microsoft, US, Trends, Startup, Fda, Novartis, Pfizer, Mitchell, US Food and Drug Administration, Los Angeles California, PitchBook, LabCorp, Cambridge Massachusetts, Takeda, ZS Associates


RMG Global wraps up biopharma fund at $64 mln

RMG Global has closed its biopharma investment fund at $64 million. The fund is  focused on biotherapeutics developed within the Israel-based FutuRx incubator, established by OrbiMed Israel, Johnson & Johnson Innovation and Takeda Ventures in cooperation with the Israel Innovation Authority. PRESS RELEASE NEW YORK, April 8, 2019 /PRNewswire/ –The RMGP Biopharma Investment Fund commenced operations immediately following the initial closing in May 2017. To date, its portfolio consists of 11 compan...
Tags: Asia, South Korea, Europe, New York, Israel, Trends, Healthcare, Funds, RMG, Iia, Johnson Johnson, Takeda, OrbiMed, Israel Innovation Authority, Yaron Breski, Takeda Ventures


Japan Olympic chief Takeda to resign from IOC

Japanese Olympic Committee (JOC) chief Tsunekazu Takeda, who is under investigation for suspected corruption, said on Tuesday he will step down from his position when his term ends in June and resign from the International Olympic Committee.
Tags: Japan, Sport, Ioc, Takeda, JOC, Tsunekazu Takeda


Japan’s Olympic Chief to Step Down Amid Corruption Investigation

Tsunekazu Takeda faces scrutiny in France over payments that prosecutors say were bribes to help Tokyo win hosting rights for the 2020 Summer Games.
Tags: Japan, News, France, Tokyo, International Olympic Committee, Takeda, Bribery and Kickbacks, Tokyo (Japan, Olympic Games (2020, Tsunekazu Takeda, Tsunekazu, Black Tidings


Japan committee chief Takeda to resign as IOC member: Kyodo

French prosecutors questioned Takeda in Paris and placed him under formal investigation in December for suspected corruption in Japan's successful bid to host the 2020 Summer Games. French investigators have led a years-long probe into corruption in athletics and in early 2016 extended their inquiry into the bidding and voting processes for the hosting of the 2016 Rio de Janeiro and the 2020 Tokyo Olympic Games. Multi-million dollar payments made by the Tokyo bid committee to a Singapore co...
Tags: Japan, News, Singapore, Paris, Tokyo, Rio De Janeiro, Ioc, Takeda, Kyodo


The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski

George Golumbeski is one of the most prolific dealmakers in the biopharmaceutical world. But the deal that changed his life is a pact he made with himself when he was ten years old.Playing with friends in front of his house in Hampton, VA, he watched his mother drag his dead-drunk father, a U.S. Air Force veteran who did a short stint in Vietnam, out of his car. Pretending to sleep in his bedroom, he’d often hear his parents screaming at each other.“I can’t end up like this,” he remembers think...
Tags: Deals, Ipo, Events, Trends, People, Depression, National, Novartis, Vietnam, Biotech, Illumina, New Enterprise Associates, Life Sciences, University Of Wisconsin, Genentech, UCB


He's spending $62 billion to transform a centuries-old Japanese company

Takeda CEO Christophe Weber made a humongous bet to take over a pharmaceutical rival.
Tags: Cnn, Takeda, Christophe Weber


Pharma giants like Novartis and Sanofi are betting that the future of healthcare looks more like an app or sensor than a prescription

Drugmakers that got their start making pills and injections worth billions are turning their attention to digital therapeutics, enabled by new technology.  Their thinking is that pharmaceuticals can only take us so far, and it's up to drugmakers and potentially technology companies to come together and figure out how to push that envelope. For instance, Japanese pharma company Otsuka got approval for a version of an antipsychotic drug embedded with a sensor that can tell doctors if you've take...
Tags: Apple, Berlin, Digital, US, Trends, Merck, Pwc, Silicon Valley, Fda, Novartis, Shire, Young, Bayer, Parkinson, Johnson Johnson, Sanofi


University of Dundee partners with Takeda to develop new treatments for tau pathology

The University of Dundee Drug Discovery Unit has announced a partnership with Takeda, Japan's largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration, including Alzheimer's disease.
Tags: Health, Takeda, University of Dundee, University of Dundee Drug Discovery Unit, Takeda Japan


Tokyo governor won't speculate on Olympic bribery scandal

The head of Tokyo's government has declined to weigh in on the future Japanese Olympic Committee President Takeda            [Author: AP]
Tags: News, Ap, Tokyo, Takeda


Tokyo governor won’t speculate on Olympic bribery scandal

TOKYO (AP) — The head of Tokyo’s city government has declined to weigh in on the future of Japanese Olympic Committee President Tsunekazu Takeda, who is being investigated for his part in an alleged bribery scandal. Asked Monday if Takeda should resign, Tokyo Governor Yurkio Koike told reporters: “This is an issue for the JOC. […]
Tags: News, Sports, Ap, Tokyo, Takeda, Tsunekazu Takeda, Yurkio Koike


Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again

Longtime biopharmaceutical executive Tachi Yamada helped keep the work of gene therapy pioneer James Wilson alive 20 years ago when Wilson was mired in controversy and the emerging field was in its darkest days.Now that gene therapy has come of age, in part because of Wilson’s work, the two are teaming up again. They’ve co-founded a startup, Passage Bio, which aims to use the technology to treat a slew of rare brain diseases.Passage, which has a broad alliance with Wilson’s gene therapy center ...
Tags: Deals, Startups, Trends, Vc, Philadelphia, Fda, National, University of Pennsylvania, GlaxoSmithKline, Parkinson's Disease, James Wilson, Life Sciences, Wilson, Clinical Trials, New Leaf Venture Partners, Takeda


U.S. jury orders Takeda to pay Bayer $155 million over hemophilia drug

A U.S. jury has ordered Takeda Pharmaceutical Co's Baxalta unit to pay Bayer AG $155.19 million for infringing a patent related to a Baxalta hemophilia treatment, court records made public on Tuesday show.
Tags: Money, businessNews, Bayer, Baxalta, Bayer AG, Takeda, Takeda Pharmaceutical Co


Canada: Abbott/Takeda Permitted To Plead That A Third Party's Patent Would Be Infringed By Alleged Non-Infringing Alternative - Smart & Biggar/Fetherstonhaugh

On the eve of a section 8 trial, the Ontario Superior Court granted Abbott and Takeda leave to amend their pleadings to assert that Apotex's purported non-infringing alternative (NIA)
Tags: News, Canada, Abbott, Ontario Superior Court, Takeda, Apotex, Biggar Fetherstonhaugh, Abbott Takeda


Tokyo Olympic CEO says no need for Takeda to resign

The chief executive of Tokyo's Olympic organizing committee says there is no need for another top Japanese official to resign despite being investigated in a bribery scandal            [Author: AP]
Tags: News, Ap, Tokyo, Takeda


Undeterred by Sanofi's stumble, Takeda takes similar path with dengue shot

A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year.
Tags: Money, businessNews, Sanofi, Takeda


Focus: Undeterred by Sanofi's stumble, Takeda takes similar path with dengue shot

A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year.
Tags: Money, businessNews, Sanofi, Takeda


Takeda dengue vaccine meets main goal of trial; detailed results to come

Takeda did not disclose how the vaccine performed in people who had never been previously exposed to dengue, a group that experienced an increased risk of severe disease with Sanofi's Dengvaxia, the world's first dengue vaccine. Sanofi had not collected blood samples on all subjects prior to beginning its trials. Takeda collected blood samples from all 20,000 children aged 4 to 16 from Asia and Latin America who participated in the Phase III TIDES trial.
Tags: Asia, Science, Latin America, Sanofi, Takeda


United States: Motion To Disqualify Based On Joint Defense Agreement Denied Where Agreement Did Not Create Implied Attorney-Client Relationship - Jeffer Mangels Butler & Mitchell LLP

In a patent infringement action, Takeda Pharmaceuticals America, Inc., and Takeda Pharmaceuticals U.S.A., Inc.'s (collectively, "Takeda") filed a motion to disqualify Baker Botts, L.L.P.
Tags: News, United States, Takeda, Mitchell LLP, Takeda Pharmaceuticals America Inc, Jeffer Mangels Butler, Takeda Pharmaceuticals U S A Inc


Olympics: Japan's Olympic Committee head to miss meeting - IOC

Japan's Olympic Committee chief Tsunekazu Takeda, investigated in France for suspected corruption linked to the Tokyo 2020 Olympics, will not attend an International Olympic Committee (IOC) marketing meeting this weekend, the IOC said on Thursday. The IOC said Takeda, an IOC member and head of the Olympic body's marketing commission, would not be traveling to Lausanne, Switzerland for a meeting of his own commission. "The IOC has been informed by Tsunekazu Takeda that he will not be at...
Tags: Japan, News, France, Tokyo, Ioc, Lausanne, Olympic Committee, Lausanne Switzerland, Takeda, International Olympic Committee IOC, Tsunekazu Takeda, Marketing Commission


Takeda corruption probe soils 2020 Tokyo Olympics and IOC

Takeda corruption probe soils 2020 Tokyo Olympics and International Olympic Committee            [Author: AP]
Tags: News, Ap, Tokyo, Ioc, Takeda


Takeda corruption probe sullies 2020 Tokyo Olympics and IOC

Takeda corruption probe soils 2020 Tokyo Olympics and International Olympic Committee            [Author: AP]
Tags: News, Ap, Tokyo, Ioc, Takeda


Japan Olympic official Takeda denies corruption allegations

TOKYO (AP) — Tsunekazu Takeda, the head of the Japanese Olympic Committee and a powerful IOC member, has denied corruption allegations against him concerning reported bribes paid to be awarded the rights to host the 2020 Olympics. A French prosecutor is investigating Takeda, who is reportedly linked to about $2 million in payments in 2013 […]
Tags: Japan, News, Sports, Ap, Nation, Olympics, Tokyo, Ioc, Takeda, Japanese Olympic Committee, Tsunekazu Takeda


Probe of IOC’s Takeda hangs over Tokyo Olympics

TOKYO (AP) — A month ago, Tsunekazu Takeda was warmly applauded by 1,400 Olympic dignitaries as he spoke alongside International Olympic Committee President Thomas Bach in Tokyo. A month later, the powerful IOC member and head of the Japanese Olympic Committee is fighting a corruption investigation, suspected by French investigators of authorizing the payment of […]
Tags: News, Sports, Ap, Nation, Olympics, Tokyo, Ioc, Takeda, Thomas Bach, Japanese Olympic Committee, Tsunekazu Takeda


Probe of IOC's Takeda hangs over Tokyo Olympics

One Tokyo newspaper has said a "Black Cloud" is hanging over the Tokyo Olympics as French prosecutors weigh corruption allegations against the head of the Japanese Olympic Committee.            [Author: AP]
Tags: News, Ap, Tokyo, Ioc, Takeda, Japanese Olympic Committee


IOC marketing chair from Japan investigated for corruption

PARIS (AP) — International Olympic Committee marketing chair Tsunekazu Takeda is being investigated for suspected corruption related to the 2020 Tokyo Olympics, France’s financial crimes office said Friday. The National Financial Prosecutors office said Takeda, who is also the president of the Japanese Olympic Committee, was placed under formal investigation for “active corruption” on Dec. […]
Tags: Japan, News, France, Sports, Ap, Nation, Olympics, Paris, Tokyo, Ioc, International Olympic Committee, Takeda, Japanese Olympic Committee, Tsunekazu Takeda, National Financial Prosecutors


Takeda unlikely to sell OTC drug business - CEO

Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it closes a $59 billion takeover of London-listed Shire, Chief Executive Christophe Weber said on Monday.
Tags: London, Money, businessNews, Shire, Takeda, Takeda Pharmaceutical, Christophe Weber


Healthcare deals hit an all-time record in 2018. See the 7 biggest tie-ups that could change how we buy drugs and treat diseases.

Healthcare dealmaking hit a record this year, and the transactions could reshape how we pay for our prescriptions and treat diseases. Big pharma companies, health insurers, and care providers have agreed to about $421 billion in transactions this year, according to data from Refinitiv. That's a record high, and amounts to 11 percent of all M&A this year. The tally from Refinitiv counts deals when they're announced, though not all transactions are ultimately completed. The dollar figures includ...
Tags: Japan, US, Trends, Cigna, GlaxoSmithKline, Novartis, Shire, GSK, Takeda, Refinitiv


New collaborative partnership in quest of novel antibiotics

The Global Antibiotic Research and Development Partnership, Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.
Tags: Health, Eisai, Takeda, Takeda Pharmaceutical Company Limited